Susan Greenfield

Susan Greenfield is a renowned British neuroscientist and pharmacologist who has made significant contributions to the field of brain research. She has held various prestigious positions, including serving as the Director of the Royal Institution from 1998 to 2010. Greenfield has also been a Professor of Pharmacology at the University of Oxford and has worked with several organizations, including the Wellcome Trust and the Medical Research Council. Her work has been recognized by the Royal Society, the Academy of Medical Sciences, and the European Dana Alliance for the Brain.

● Early Life and Education

Greenfield was born in London, England, and grew up in a family of Jewish descent. She attended Godolphin and Latymer School in Hammersmith and later studied Pharmacology at St Hilda's College, Oxford. Greenfield earned her Doctor of Philosophy degree from the University of Oxford in 1977, where she worked under the supervision of Professor Anthony David Smith at the Department of Pharmacology. Her early research focused on the neurotransmitter acetylcholine and its role in Alzheimer's disease, a condition also studied by Alois Alzheimer and David Perlmutter.

● Career

Greenfield's career has spanned several institutions, including the University of Oxford, where she was a Lecturer in Pharmacology and later a Professor of Pharmacology. She has also worked at the University of Cambridge, University College London, and the Institute of Psychiatry, King's College London. Greenfield has been a Fellow of the Royal Society since 2000 and has served on the Council of the Royal Society from 2005 to 2007. She has also been a member of the Scientific Advisory Board of the European Brain Council and has worked with organizations such as the World Health Organization and the National Institute of Mental Health.

● Research and Publications

Greenfield's research has focused on the neurobiology of brain disorders, including Alzheimer's disease, Parkinson's disease, and depression. She has published numerous papers in scientific journals, including Nature, Science, and the Journal of Neuroscience. Greenfield has also written several books, including The Human Brain: A Guided Tour and ID: The Quest for Identity in the 21st Century, which explore the neuroscience of human behavior and identity. Her work has been influenced by neuroscientists such as Eric Kandel, Vilayanur Ramachandran, and Oliver Sacks.

● Awards and Honours

Greenfield has received several awards and honors for her contributions to neuroscience and pharmacology. She was awarded the Royal Society's Michael Faraday Prize in 1995 for her work in communicating science to the public. Greenfield has also received the CBE in the 2000 New Year Honours for her services to science and has been awarded honorary degrees from several universities, including the University of Cambridge, University of Oxford, and University of St Andrews. She has been recognized by organizations such as the American Academy of Arts and Sciences, the Academia Europaea, and the European Academy of Sciences and Arts.

● Public Life and Media Appearances

Greenfield has been a prominent figure in the media, appearing on BBC Radio 4, BBC One, and Channel 4. She has presented several documentary series, including Brain Story and The Truth About the Brain, which explore the neuroscience of human behavior and brain function. Greenfield has also written for several newspapers, including The Times, The Guardian, and The Daily Telegraph. She has been a columnist for The Observer and has written for The New York Times and The Wall Street Journal.

● Criticisms and Controversies

Greenfield has been involved in several controversies throughout her career, including a public dispute with the Royal Institution over her management style and financial decisions. She has also been criticized for her views on the impact of technology on brain development and cognitive function, which have been challenged by experts such as Steven Pinker and Nicholas Carr. Greenfield has responded to these criticisms, arguing that her work is based on scientific evidence and that she is committed to public engagement and science communication. Despite these controversies, Greenfield remains a prominent figure in the scientific community, known for her contributions to neuroscience and pharmacology and her commitment to public understanding of science.